Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
115 hedge funds and large institutions have $630M invested in Gritstone bio, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 42 increasing their positions, 27 reducing their positions, and 11 closing their positions.
209% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 11
70% more call options, than puts
Call options by funds: $9.2M | Put options by funds: $5.43M
56% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 27
37% more capital invested
Capital invested by funds: $458M → $630M (+$171M)
25% more funds holding
Funds holding: 92 → 115 (+23)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$32.2M |
| 2 |
AG
Artal Group
Luxembourg
|
+$8.31M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.22M |
| 4 |
BlackRock
New York
|
+$6.83M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$6.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$16.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.9M |
| 3 |
D.E. Shaw & Co
New York
|
-$10.8M |
| 4 |
VVM
Versant Venture Management
San Francisco,
California
|
-$4.92M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.74M |
GRTS Hedge Fund Activity: Q4 2021 in Review
115 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q4 2021, worth a combined $630M — up 37% from $458M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new GRTS positions and 11 closed out — a net gain of 23 holders — while 42 added to existing stakes and 27 trimmed.
The largest buyer was State Street, adding an estimated $32.2M. The largest seller was BVF Inc, exiting entirely with an estimated $16.5M sold.
- 115 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q4 2021, up from 92 in Q3 2021.
- Funds reported $630M of Gritstone bio, Inc. Common Stock stock for Q4 2021, up 37% quarter-over-quarter.
- 34 funds opened new Gritstone bio, Inc. Common Stock positions in Q4 2021 and 11 closed out, a net change of +23 holders.
- The largest Gritstone bio, Inc. Common Stock buyer in Q4 2021 was State Street, an estimated $32.2M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q4 2021 was BVF Inc, an estimated $16.5M sold.
Based on aggregated 13F filings for Q4 2021.